<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01994759</url>
  </required_header>
  <id_info>
    <org_study_id>H-2-2012-150-FJ</org_study_id>
    <nct_id>NCT01994759</nct_id>
  </id_info>
  <brief_title>Optimal Treatment of Plantar Fasciitis: Physical Training, Glucocorticoid Injections or a Combination Thereof.</brief_title>
  <official_title>Optimal Treatment of Plantar Fasciitis: A Randomized Clinical Trial Using Physical Training, Glucocorticoid Injections or a Combination Thereof.</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Bispebjerg Hospital</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Fonden for Faglig Udvikling af Speciallægepraksis, Denmark</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Bispebjerg Hospital</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this study is to determine whether reduced load to patients with plantar
      fasciitis (reduced standing, walking, landing) together with either controlled heavy
      resistance training or glucocorticosteroid injection or a combination thereof is the best
      treatment.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Plantar fasciitis (PF) is a frequently diagnosed condition, defined as pain at the medial
      tubercle of the calcaneus, and 10% of the population will at some points in their life
      experience this condition. Accumulated loading of the plantar fascia seems to relate to
      development of PF, as it is commonly seen in runners and those who are overweight, and number
      of daily steps or simply time of standing has been shown to be a predisposing factor for PF
      development.

      Orthosis and glucocorticoid injections are 2 widely used treatments with proven effect.
      However treatment of overuse injury in other tendon/aponeurosis-like structures, has over the
      later years been dominated by an increasing documentation of a good curative effect of heavy
      controlled mechanical loading (eccentric strength exercises or heavy slow concentric strength
      training) upon tendinopathies in Achilles or patella tendon. However, no studies have looked
      at the influence of physical training (e.g. strength training) on the diseased plantar
      aponeurosis. Also no studies have looked at the effect of a combination of giving local
      glucocorticoid injection and training on this or other tendon overuse entities.

      We hypothesize that heavy strength training will have a positive effect upon PF, and that a
      combination of training and glucocorticoid injections will have an additive effect upon this
      disease and be even more effective than each of the treatments alone. Glucocorticoid
      injection acting as the standard control treatment.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">September 1, 2013</start_date>
  <completion_date type="Actual">December 1, 2016</completion_date>
  <primary_completion_date type="Actual">July 1, 2015</primary_completion_date>
  <phase>Phase 4</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Single (Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>100 mm VAS score pain at function. Average pain during everyday living.</measure>
    <time_frame>6 month</time_frame>
  </primary_outcome>
  <primary_outcome>
    <measure>Foot Function Index</measure>
    <time_frame>6 month</time_frame>
    <description>Foot function Index is a validated score for patients with plantar fasciitis. It consists of 23 questions concerning pain, function and impact on daily life. Each question is answered on a box scale 0-10, giving a score range: 0-230.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>100 mm VAS score for morning pain</measure>
    <time_frame>at entry, 3 month (after intervention), 6 month, 12 month, 24 month</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Ultrasound scanning thickness measure</measure>
    <time_frame>at entry, 3 month (after intervention), 6 month, 12 month, 24 month</time_frame>
    <description>measurement of the thickness of the thickest part of the fascia by B-mode Ultrasound scanning</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>100 mm VAS score pain at function. Average pain during everyday living.</measure>
    <time_frame>3 months, 12 months, 24 months</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Foot Function Index</measure>
    <time_frame>3 month, 12 month, 24 month</time_frame>
    <description>Foot function Index is a validated score for patients with plantar fasciitis. It consists of 23 questions concerning pain, function and impact on daily life. Each question is answered on a box scale 0-10, giving a score range: 0-230.</description>
  </secondary_outcome>
  <other_outcome>
    <measure>patient diary</measure>
    <time_frame>week 1,2,3,4,5,6,7,8,9,10,11,12,13</time_frame>
    <description>100 mm VAS score for morning pain (average in the week). 100 mm VAS score for pain at function (average in the week). Compliance to the treatment. Side effects to glucocorticosteroid injections is described.</description>
  </other_outcome>
  <other_outcome>
    <measure>Contrast Enhanced Ultrasound</measure>
    <time_frame>at entry after 3-4 months and after 1 year</time_frame>
    <description>For determining bloodflow of the plantar fascia we inject 2 ml SonoVue®. Ultrasound contrast agent, that amplifies the ultrasound signal. After injection we simultaneously ultrasound scan both feet for 3 minutes. The perfusion of the fascia can hereby bee calculated.
Only patients with unilateral plantar fasciitis will bee offered this evaluation.</description>
  </other_outcome>
  <number_of_arms>3</number_of_arms>
  <enrollment type="Actual">90</enrollment>
  <condition>Plantar Fasciitis</condition>
  <arm_group>
    <arm_group_label>Training</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>strengthening and stretching exercises.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Glucocorticosteroid injection</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Injection of 40 mg methylprednisolone.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Training and Glucocorticosteroid injections</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>A combination treatment of the two above.</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Training</intervention_name>
    <description>Patients are instructed to carry out strengthening exercises for the fascia plantaris 3 days a week and stretching exercises every day. Four times in the first 2 months supervised training in groups is carried out with a physiotherapist supervising the exercises and instructing in progression and new exercises, and all participants are instructed to carry out a specific training program daily at home. The amount of training performed by each patient, is registered in a diary weekly</description>
    <arm_group_label>Training</arm_group_label>
    <arm_group_label>Training and Glucocorticosteroid injections</arm_group_label>
    <other_name>Heavy slow resistance exercise</other_name>
    <other_name>Eccentric training</other_name>
    <other_name>stretching</other_name>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Glucocorticosteroid injection</intervention_name>
    <description>Ultra sound guided injection af 1 ml og Glucocorticosteroid (methylprednisolone 40 mg) and 1 ml of lidocaine 5mg/ml from the medial side profound to the thickened part of the fascia plantaris.
Glucocorticosteroid injections are given every month until the aponeurosis thickness is less than 4 mm as determined by ultrasonography (max 3 injections).</description>
    <arm_group_label>Glucocorticosteroid injection</arm_group_label>
    <arm_group_label>Training and Glucocorticosteroid injections</arm_group_label>
    <other_name>Methylprednisolone</other_name>
    <other_name>Depo-medrol</other_name>
  </intervention>
  <intervention>
    <intervention_type>Behavioral</intervention_type>
    <intervention_name>Reduction in impact</intervention_name>
    <description>advocate reduction in standing, walking, running, jumping. advocate shock absorbing shoes advocate prefabricated insoles advocate taping in special occasions.</description>
    <arm_group_label>Training</arm_group_label>
    <arm_group_label>Glucocorticosteroid injection</arm_group_label>
    <arm_group_label>Training and Glucocorticosteroid injections</arm_group_label>
    <other_name>Shock absorbtion</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Pain at the medial attachment of fascia plantaris.

          -  First step pain in the morning

          -  Symptoms for at least 3 months.

          -  Age 20-65 years

          -  Ultrasound scanning at the first visit shows thickness of the fascia above 4 mm.

          -  Patient can read and understand danish

        Exclusion Criteria:

          -  known arthritis, inflammatory bowl disease, psoriasis or clinical signs of any of
             these

          -  Leg ulcerations

          -  Longlasting oedema of the leg and foot

          -  Palpatory decreased puls in the foot

          -  Diabetes

          -  Reduced sensibility in the foot

          -  Infections in the foot

          -  Daily use of pain killers

          -  Pregnancy or planning to become pregnant

          -  Earlier operations on the foot, that is judged to complicate training

          -  Patient assessed not to be able to participate in the training for other reasons

          -  Glucocorticosteroid injection to the diseased plantar fascia within the last 6 months.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>20 Years</minimum_age>
    <maximum_age>65 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Michael Kjær, Professor</last_name>
    <role>Study Chair</role>
    <affiliation>University of Copenhagen</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Institute of Sports Medicine Copenhagen, Bispebjerg Hospital</name>
      <address>
        <city>Kobenhavn</city>
        <zip>2400</zip>
        <country>Denmark</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Denmark</country>
  </location_countries>
  <reference>
    <citation>Baldassin V, Gomes CR, Beraldo PS. Effectiveness of prefabricated and customized foot orthoses made from low-cost foam for noncomplicated plantar fasciitis: a randomized controlled trial. Arch Phys Med Rehabil. 2009 Apr;90(4):701-6. doi: 10.1016/j.apmr.2008.11.002.</citation>
    <PMID>19345789</PMID>
  </reference>
  <reference>
    <citation>Crawford F, Thomson C. Interventions for treating plantar heel pain. Cochrane Database Syst Rev. 2003;(3):CD000416. Review. Update in: Cochrane Database Syst Rev. 2010;(1):CD000416.</citation>
    <PMID>12917892</PMID>
  </reference>
  <reference>
    <citation>Uden H, Boesch E, Kumar S. Plantar fasciitis - to jab or to support? A systematic review of the current best evidence. J Multidiscip Healthc. 2011;4:155-64. doi: 10.2147/JMDH.S20053. Epub 2011 May 24.</citation>
    <PMID>21655342</PMID>
  </reference>
  <reference>
    <citation>Vohra PK, Kincaid BR, Japour CJ, Sobel E. Ultrasonographic evaluation of plantar fascia bands. A retrospective study of 211 symptomatic feet. J Am Podiatr Med Assoc. 2002 Sep;92(8):444-9.</citation>
    <PMID>12237265</PMID>
  </reference>
  <reference>
    <citation>Tobin L, Simonsen L, Bülow J. Real-time contrast-enhanced ultrasound determination of microvascular blood volume in abdominal subcutaneous adipose tissue in man. Evidence for adipose tissue capillary recruitment. Clin Physiol Funct Imaging. 2010 Nov;30(6):447-52. doi: 10.1111/j.1475-097X.2010.00964.x. Epub 2010 Aug 22.</citation>
    <PMID>20731685</PMID>
  </reference>
  <reference>
    <citation>Roos E, Engström M, Söderberg B. Foot orthoses for the treatment of plantar fasciitis. Foot Ankle Int. 2006 Aug;27(8):606-11.</citation>
    <PMID>16919213</PMID>
  </reference>
  <reference>
    <citation>Radford JA, Landorf KB, Buchbinder R, Cook C. Effectiveness of low-Dye taping for the short-term treatment of plantar heel pain: a randomised trial. BMC Musculoskelet Disord. 2006 Aug 9;7:64.</citation>
    <PMID>16895612</PMID>
  </reference>
  <reference>
    <citation>Pfeffer G, Bacchetti P, Deland J, Lewis A, Anderson R, Davis W, Alvarez R, Brodsky J, Cooper P, Frey C, Herrick R, Myerson M, Sammarco J, Janecki C, Ross S, Bowman M, Smith R. Comparison of custom and prefabricated orthoses in the initial treatment of proximal plantar fasciitis. Foot Ankle Int. 1999 Apr;20(4):214-21.</citation>
    <PMID>10229276</PMID>
  </reference>
  <reference>
    <citation>Kongsgaard M, Kovanen V, Aagaard P, Doessing S, Hansen P, Laursen AH, Kaldau NC, Kjaer M, Magnusson SP. Corticosteroid injections, eccentric decline squat training and heavy slow resistance training in patellar tendinopathy. Scand J Med Sci Sports. 2009 Dec;19(6):790-802. doi: 10.1111/j.1600-0838.2009.00949.x. Epub 2009 May 28.</citation>
    <PMID>19793213</PMID>
  </reference>
  <reference>
    <citation>Cheng JW, Tsai WC, Yu TY, Huang KY. Reproducibility of sonographic measurement of thickness and echogenicity of the plantar fascia. J Clin Ultrasound. 2012 Jan;40(1):14-9. doi: 10.1002/jcu.20903. Epub 2011 Nov 22.</citation>
    <PMID>22109854</PMID>
  </reference>
  <verification_date>March 2017</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>November 10, 2013</study_first_submitted>
  <study_first_submitted_qc>November 21, 2013</study_first_submitted_qc>
  <study_first_posted type="Estimate">November 26, 2013</study_first_posted>
  <last_update_submitted>March 1, 2017</last_update_submitted>
  <last_update_submitted_qc>March 1, 2017</last_update_submitted_qc>
  <last_update_posted type="Actual">March 3, 2017</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Bispebjerg Hospital</investigator_affiliation>
    <investigator_full_name>Finn Elkjær Johannsen</investigator_full_name>
    <investigator_title>chief physician, MD, specialist in Rheumatology</investigator_title>
  </responsible_party>
  <keyword>Plantar fasciitis</keyword>
  <keyword>Treatment</keyword>
  <keyword>Training</keyword>
  <keyword>Glucocorticosteroid injection</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Fasciitis</mesh_term>
    <mesh_term>Fasciitis, Plantar</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Prednisolone acetate</mesh_term>
    <mesh_term>Methylprednisolone acetate</mesh_term>
    <mesh_term>Methylprednisolone</mesh_term>
    <mesh_term>Methylprednisolone Hemisuccinate</mesh_term>
    <mesh_term>Prednisolone</mesh_term>
    <mesh_term>Prednisolone hemisuccinate</mesh_term>
    <mesh_term>Prednisolone phosphate</mesh_term>
    <mesh_term>Glucocorticoids</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

